4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarbonitrile, 95.0%, 250mg

BUTANEDINITRILE, 2,3-DIMETHYL-2,3-BIS(2-METHYLPROPYL)-, 95%, 250mg

(6-Bromo-3-fluoro-2-methoxyphenyl)boronic acid, 95.0%, 250mg

7-Methyl-2-phenyl-imidazo[1,2-a]pyridine-3-carbaldehyde, 95.0%, 1g

(2E)-1-(3-bromophenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(S)-3-(3-fluorophenyl)-2-hydroxypropanoic acid, 98%, 5g

EMD 387008 (R-IMEGLIMIN) HCL, 95.0%, 5mg

(2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamidehydrochloride, 95%, 100mg

3-(2-Fluoro-phenoxy)-propionic acid, 95.0%, 5g

6-Iodo-1-methyl-1H-indazole, 95.0%, 1g

Büchner funnel glass 250 ml NS 29/32

{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}amine, 95.0%, 1g

Slide with phase contrast cancellation 40x for Abbe condenser with opening for bScope. Needs condenser with orifice (BS.9102)